- Sustained enforcement against misleading GLP-1 marketing claims by the FDA against regulated companies.
- Eli Lilly warns the FDA about black market drug sales, while U.S. Customs and Border Protection intercepts shipments of illicit GLP-1 drugs.
Eli Lilly's drug is being tested for market approval while also being advertised for illicit sales on TikTok in Brighton.
1 report, 1 independent
Updated Sep 4
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Eli Lilly's drug is being tested for market approval while also being advertised for illicit sales on TikTok in Brighton.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Eli Lilly and Company
American pharmaceutical company
- FDA
Related events
- Eli Lilly and Company plans to submit a drug candidate to the FDA for review and approval.
- An experimental drug, sourced from China, is under FDA scrutiny after marketing claims of being 'the ultimate good' and subsequent warnings were issued.
- The FDA has questioned promotional materials related to an investigational drug from Alar Pharmaceuticals.
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
- The FDA is currently reviewing new drug applications for market entry.